Verastem | VSTM - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
AbbVie USD 9.39B 4.16B 2026-03
Alaunos Therapeutics USD 1.38M 553K 2025-12
AstraZeneca USD 7.56B 1.85B 2026-03
Curis USD 10.14M 10.14M 2025-06
Cytokinetics USD 129.84M 7.32M 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
Incyte USD 4.02B 435.22M 2026-03
Laboratory Of America USD 981.1M 448.8M 2026-03
Novartis USD 6.88B 4.56B 2026-03
Pfizer USD 1.7B 561M 2026-03
Roche Holding CHF 7.55B 579M 2025-06
TG Therapeutics USD 442.21M 242.7M 2026-03
Verastem USD 204.99M 67.28M 2025-12